Martins Patrícia S, Ochoa Rosemary, Pimenta Adriano M C, Ferreira Lucas A M, Melo Alan L, da Silva José B B, Sinisterra Rubén D, Demicheli Cynthia, Frézard Frédéric
Departamento de Fisiologia e Biofísica, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Av. Antônio Carlos 6627, Pampulha, 31270-901 Belo Horizonte, MG, Brazil.
Int J Pharm. 2006 Nov 15;325(1-2):39-47. doi: 10.1016/j.ijpharm.2006.06.014. Epub 2006 Jun 13.
It has been previously reported that beta-cyclodextrin (beta-CD) enhances the oral absorption of the pentavalent antimony (Sb) drug, meglumine antimoniate (MA). Contrary to the drugs commonly used in association with beta-CD, MA is highly soluble in water (solubility >300 mg/mL) and, therefore, the mode of action of beta-CD in this system requires clarification. ESI(-)-MS analysis of MA and of the MA/beta-CD composition indicated the formation of a 1:1 association compound between 1:1 Sb-meglumine complex and beta-CD. A stability constant on the order of 100 Lmol(-1) was determined for this association compound. When MA solution was heated for 48 h at 55 degrees C to mimic the conditions used to prepare MA/beta-CD, MA was found to suffer dissociation, from high molecular weight Sb complexes into species of lower molecular weight. Strikingly, heated MA was found to be more extensively absorbed in mice by the oral route than MA freshly prepared at room temperature. In vitro skin permeation experiments using MA and MA/beta-CD indicated a two-fold increase in the Sb flux for MA/beta-CD. These findings support the hypothesis that the improved oral absorption of Sb arises from the increased permeation of MA across lipid bilayers, as a result of the enhanced availability of 1:1 Sb-meglumine complex.
此前已有报道称,β-环糊精(β-CD)可增强五价锑(Sb)药物葡甲胺锑酸盐(MA)的口服吸收。与通常与β-CD联合使用的药物不同,MA在水中高度可溶(溶解度>300 mg/mL),因此,β-CD在该系统中的作用方式需要阐明。对MA以及MA/β-CD组合物进行电喷雾电离负离子质谱(ESI(-)-MS)分析表明,在1:1的Sb-葡甲胺络合物与β-CD之间形成了1:1的缔合化合物。测定该缔合化合物的稳定常数约为100 Lmol(-1)。当将MA溶液在55℃加热48小时以模拟制备MA/β-CD所用的条件时,发现MA会发生解离,从高分子量的Sb络合物分解为较低分子量的物质。引人注目的是,发现加热后的MA经口服途径在小鼠体内的吸收比在室温下新鲜制备的MA更广泛。使用MA和MA/β-CD进行的体外皮肤渗透实验表明,MA/β-CD的Sb通量增加了两倍。这些发现支持了这样一种假设,即Sb口服吸收的改善源于MA跨脂质双层的渗透性增加,这是由于1:1的Sb-葡甲胺络合物可用性增强的结果。